世界の前部ブドウ膜炎治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Anterior Uveitis Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z0360
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、95ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥553,800 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥830,700 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,107,600 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、前部ブドウ膜炎治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（コルチコステロイド、毛様体筋麻痺薬、抗TNF薬、免疫抑制剤）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・前部ブドウ膜炎治療の市場動向
・企業の競争状況、市場シェア
・前部ブドウ膜炎治療の種類別市場規模（コルチコステロイド、毛様体筋麻痺薬、抗TNF薬、免疫抑制剤）
・前部ブドウ膜炎治療の用途別市場規模（病院、クリニック、その他）
・前部ブドウ膜炎治療の北米市場規模2016-2027（アメリカ、カナダ）
・前部ブドウ膜炎治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・前部ブドウ膜炎治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・前部ブドウ膜炎治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・前部ブドウ膜炎治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Novartis AG、Santen Pharmaceutical Co.、AbbVie Inc.、Eyegate Pharmaceuticals Inc.、Clearside Biomedical Inc.、Aldeyra Therapeutics Inc.、Aciont Inc.、Sirion Therapeutics Inc.、UCB Biopharma S.P.R.L.、Lux Biosciences Inc.）
・結論

Market Analysis and Insights: Global Anterior Uveitis Treatment Market
The global Anterior Uveitis Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Anterior Uveitis Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Anterior Uveitis Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Anterior Uveitis Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Anterior Uveitis Treatment market.

Global Anterior Uveitis Treatment Scope and Market Size
Anterior Uveitis Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Anterior Uveitis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Corticosteroids
Cycloplegic Agents
Anti-TNF Agents
Immunosuppressants

Segment by Application
Hospitals
Clinics
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Novartis AG
Santen Pharmaceutical Co.
AbbVie Inc.
Eyegate Pharmaceuticals Inc.
Clearside Biomedical Inc.
Aldeyra Therapeutics Inc.
Aciont Inc.
Sirion Therapeutics Inc.
UCB Biopharma S.P.R.L.

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anterior Uveitis Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Corticosteroids
1.2.3 Cycloplegic Agents
1.2.4 Anti-TNF Agents
1.2.5 Immunosuppressants
1.3 Market by Application
1.3.1 Global Anterior Uveitis Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Anterior Uveitis Treatment Market Perspective (2016-2027)
2.2 Anterior Uveitis Treatment Growth Trends by Regions
2.2.1 Anterior Uveitis Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Anterior Uveitis Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Anterior Uveitis Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Anterior Uveitis Treatment Industry Dynamic
2.3.1 Anterior Uveitis Treatment Market Trends
2.3.2 Anterior Uveitis Treatment Market Drivers
2.3.3 Anterior Uveitis Treatment Market Challenges
2.3.4 Anterior Uveitis Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Anterior Uveitis Treatment Players by Revenue
3.1.1 Global Top Anterior Uveitis Treatment Players by Revenue (2016-2021)
3.1.2 Global Anterior Uveitis Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Anterior Uveitis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Anterior Uveitis Treatment Revenue
3.4 Global Anterior Uveitis Treatment Market Concentration Ratio
3.4.1 Global Anterior Uveitis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anterior Uveitis Treatment Revenue in 2020
3.5 Anterior Uveitis Treatment Key Players Head office and Area Served
3.6 Key Players Anterior Uveitis Treatment Product Solution and Service
3.7 Date of Enter into Anterior Uveitis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Anterior Uveitis Treatment Breakdown Data by Type
4.1 Global Anterior Uveitis Treatment Historic Market Size by Type (2016-2021)
4.2 Global Anterior Uveitis Treatment Forecasted Market Size by Type (2022-2027)

5 Anterior Uveitis Treatment Breakdown Data by Application
5.1 Global Anterior Uveitis Treatment Historic Market Size by Application (2016-2021)
5.2 Global Anterior Uveitis Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Anterior Uveitis Treatment Market Size (2016-2027)
6.2 North America Anterior Uveitis Treatment Market Size by Type
6.2.1 North America Anterior Uveitis Treatment Market Size by Type (2016-2021)
6.2.2 North America Anterior Uveitis Treatment Market Size by Type (2022-2027)
6.2.3 North America Anterior Uveitis Treatment Market Size by Type (2016-2027)
6.3 North America Anterior Uveitis Treatment Market Size by Application
6.3.1 North America Anterior Uveitis Treatment Market Size by Application (2016-2021)
6.3.2 North America Anterior Uveitis Treatment Market Size by Application (2022-2027)
6.3.3 North America Anterior Uveitis Treatment Market Size by Application (2016-2027)
6.4 North America Anterior Uveitis Treatment Market Size by Country
6.4.1 North America Anterior Uveitis Treatment Market Size by Country (2016-2021)
6.4.2 North America Anterior Uveitis Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Anterior Uveitis Treatment Market Size (2016-2027)
7.2 Europe Anterior Uveitis Treatment Market Size by Type
7.2.1 Europe Anterior Uveitis Treatment Market Size by Type (2016-2021)
7.2.2 Europe Anterior Uveitis Treatment Market Size by Type (2022-2027)
7.2.3 Europe Anterior Uveitis Treatment Market Size by Type (2016-2027)
7.3 Europe Anterior Uveitis Treatment Market Size by Application
7.3.1 Europe Anterior Uveitis Treatment Market Size by Application (2016-2021)
7.3.2 Europe Anterior Uveitis Treatment Market Size by Application (2022-2027)
7.3.3 Europe Anterior Uveitis Treatment Market Size by Application (2016-2027)
7.4 Europe Anterior Uveitis Treatment Market Size by Country
7.4.1 Europe Anterior Uveitis Treatment Market Size by Country (2016-2021)
7.4.2 Europe Anterior Uveitis Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Anterior Uveitis Treatment Market Size (2016-2027)
8.2 Asia-Pacific Anterior Uveitis Treatment Market Size by Type
8.2.1 Asia-Pacific Anterior Uveitis Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Anterior Uveitis Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Anterior Uveitis Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Anterior Uveitis Treatment Market Size by Application
8.3.1 Asia-Pacific Anterior Uveitis Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Anterior Uveitis Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Anterior Uveitis Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Anterior Uveitis Treatment Market Size by Region
8.4.1 Asia-Pacific Anterior Uveitis Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Anterior Uveitis Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Anterior Uveitis Treatment Market Size (2016-2027)
9.2 Latin America Anterior Uveitis Treatment Market Size by Type
9.2.1 Latin America Anterior Uveitis Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Anterior Uveitis Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Anterior Uveitis Treatment Market Size by Type (2016-2027)
9.3 Latin America Anterior Uveitis Treatment Market Size by Application
9.3.1 Latin America Anterior Uveitis Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Anterior Uveitis Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Anterior Uveitis Treatment Market Size by Application (2016-2027)
9.4 Latin America Anterior Uveitis Treatment Market Size by Country
9.4.1 Latin America Anterior Uveitis Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Anterior Uveitis Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Anterior Uveitis Treatment Market Size (2016-2027)
10.2 Middle East & Africa Anterior Uveitis Treatment Market Size by Type
10.2.1 Middle East & Africa Anterior Uveitis Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Anterior Uveitis Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Anterior Uveitis Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Anterior Uveitis Treatment Market Size by Application
10.3.1 Middle East & Africa Anterior Uveitis Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Anterior Uveitis Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Anterior Uveitis Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Anterior Uveitis Treatment Market Size by Country
10.4.1 Middle East & Africa Anterior Uveitis Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Anterior Uveitis Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Novartis AG
11.1.1 Novartis AG Company Details
11.1.2 Novartis AG Business Overview
11.1.3 Novartis AG Anterior Uveitis Treatment Introduction
11.1.4 Novartis AG Revenue in Anterior Uveitis Treatment Business (2016-2021)
11.1.5 Novartis AG Recent Development
11.2 Santen Pharmaceutical Co.
11.2.1 Santen Pharmaceutical Co. Company Details
11.2.2 Santen Pharmaceutical Co. Business Overview
11.2.3 Santen Pharmaceutical Co. Anterior Uveitis Treatment Introduction
11.2.4 Santen Pharmaceutical Co. Revenue in Anterior Uveitis Treatment Business (2016-2021)
11.2.5 Santen Pharmaceutical Co. Recent Development
11.3 AbbVie Inc.
11.3.1 AbbVie Inc. Company Details
11.3.2 AbbVie Inc. Business Overview
11.3.3 AbbVie Inc. Anterior Uveitis Treatment Introduction
11.3.4 AbbVie Inc. Revenue in Anterior Uveitis Treatment Business (2016-2021)
11.3.5 AbbVie Inc. Recent Development
11.4 Eyegate Pharmaceuticals Inc.
11.4.1 Eyegate Pharmaceuticals Inc. Company Details
11.4.2 Eyegate Pharmaceuticals Inc. Business Overview
11.4.3 Eyegate Pharmaceuticals Inc. Anterior Uveitis Treatment Introduction
11.4.4 Eyegate Pharmaceuticals Inc. Revenue in Anterior Uveitis Treatment Business (2016-2021)
11.4.5 Eyegate Pharmaceuticals Inc. Recent Development
11.5 Clearside Biomedical Inc.
11.5.1 Clearside Biomedical Inc. Company Details
11.5.2 Clearside Biomedical Inc. Business Overview
11.5.3 Clearside Biomedical Inc. Anterior Uveitis Treatment Introduction
11.5.4 Clearside Biomedical Inc. Revenue in Anterior Uveitis Treatment Business (2016-2021)
11.5.5 Clearside Biomedical Inc. Recent Development
11.6 Aldeyra Therapeutics Inc.
11.6.1 Aldeyra Therapeutics Inc. Company Details
11.6.2 Aldeyra Therapeutics Inc. Business Overview
11.6.3 Aldeyra Therapeutics Inc. Anterior Uveitis Treatment Introduction
11.6.4 Aldeyra Therapeutics Inc. Revenue in Anterior Uveitis Treatment Business (2016-2021)
11.6.5 Aldeyra Therapeutics Inc. Recent Development
11.7 Aciont Inc.
11.7.1 Aciont Inc. Company Details
11.7.2 Aciont Inc. Business Overview
11.7.3 Aciont Inc. Anterior Uveitis Treatment Introduction
11.7.4 Aciont Inc. Revenue in Anterior Uveitis Treatment Business (2016-2021)
11.7.5 Aciont Inc. Recent Development
11.8 Sirion Therapeutics Inc.
11.8.1 Sirion Therapeutics Inc. Company Details
11.8.2 Sirion Therapeutics Inc. Business Overview
11.8.3 Sirion Therapeutics Inc. Anterior Uveitis Treatment Introduction
11.8.4 Sirion Therapeutics Inc. Revenue in Anterior Uveitis Treatment Business (2016-2021)
11.8.5 Sirion Therapeutics Inc. Recent Development
11.9 UCB Biopharma S.P.R.L.
11.9.1 UCB Biopharma S.P.R.L. Company Details
11.9.2 UCB Biopharma S.P.R.L. Business Overview
11.9.3 UCB Biopharma S.P.R.L. Anterior Uveitis Treatment Introduction
11.9.4 UCB Biopharma S.P.R.L. Revenue in Anterior Uveitis Treatment Business (2016-2021)
11.9.5 UCB Biopharma S.P.R.L. Recent Development
11.10 Lux Biosciences Inc.
11.10.1 Lux Biosciences Inc. Company Details
11.10.2 Lux Biosciences Inc. Business Overview
11.10.3 Lux Biosciences Inc. Anterior Uveitis Treatment Introduction
11.10.4 Lux Biosciences Inc. Revenue in Anterior Uveitis Treatment Business (2016-2021)
11.10.5 Lux Biosciences Inc. Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Anterior Uveitis Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Corticosteroids
Table 3. Key Players of Cycloplegic Agents
Table 4. Key Players of Anti-TNF Agents
Table 5. Key Players of Immunosuppressants
Table 6. Global Anterior Uveitis Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Anterior Uveitis Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Anterior Uveitis Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Anterior Uveitis Treatment Market Share by Regions (2016-2021)
Table 10. Global Anterior Uveitis Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Anterior Uveitis Treatment Market Share by Regions (2022-2027)
Table 12. Anterior Uveitis Treatment Market Trends
Table 13. Anterior Uveitis Treatment Market Drivers
Table 14. Anterior Uveitis Treatment Market Challenges
Table 15. Anterior Uveitis Treatment Market Restraints
Table 16. Global Anterior Uveitis Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Anterior Uveitis Treatment Market Share by Players (2016-2021)
Table 18. Global Top Anterior Uveitis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anterior Uveitis Treatment as of 2020)
Table 19. Ranking of Global Top Anterior Uveitis Treatment Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Anterior Uveitis Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Anterior Uveitis Treatment Product Solution and Service
Table 23. Date of Enter into Anterior Uveitis Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Anterior Uveitis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Anterior Uveitis Treatment Revenue Market Share by Type (2016-2021)
Table 27. Global Anterior Uveitis Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Anterior Uveitis Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Anterior Uveitis Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Anterior Uveitis Treatment Revenue Market Share by Application (2016-2021)
Table 31. Global Anterior Uveitis Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Anterior Uveitis Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Anterior Uveitis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Anterior Uveitis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Anterior Uveitis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Anterior Uveitis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Anterior Uveitis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Anterior Uveitis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Anterior Uveitis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Anterior Uveitis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Anterior Uveitis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Anterior Uveitis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Anterior Uveitis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Anterior Uveitis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Anterior Uveitis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Anterior Uveitis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Anterior Uveitis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Anterior Uveitis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Anterior Uveitis Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Anterior Uveitis Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Anterior Uveitis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Anterior Uveitis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Anterior Uveitis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Anterior Uveitis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Anterior Uveitis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Anterior Uveitis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Anterior Uveitis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Anterior Uveitis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Anterior Uveitis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Anterior Uveitis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Anterior Uveitis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Anterior Uveitis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 63. Novartis AG Company Details
Table 64. Novartis AG Business Overview
Table 65. Novartis AG Anterior Uveitis Treatment Product
Table 66. Novartis AG Revenue in Anterior Uveitis Treatment Business (2016-2021) & (US$ Million)
Table 67. Novartis AG Recent Development
Table 68. Santen Pharmaceutical Co. Company Details
Table 69. Santen Pharmaceutical Co. Business Overview
Table 70. Santen Pharmaceutical Co. Anterior Uveitis Treatment Product
Table 71. Santen Pharmaceutical Co. Revenue in Anterior Uveitis Treatment Business (2016-2021) & (US$ Million)
Table 72. Santen Pharmaceutical Co. Recent Development
Table 73. AbbVie Inc. Company Details
Table 74. AbbVie Inc. Business Overview
Table 75. AbbVie Inc. Anterior Uveitis Treatment Product
Table 76. AbbVie Inc. Revenue in Anterior Uveitis Treatment Business (2016-2021) & (US$ Million)
Table 77. AbbVie Inc. Recent Development
Table 78. Eyegate Pharmaceuticals Inc. Company Details
Table 79. Eyegate Pharmaceuticals Inc. Business Overview
Table 80. Eyegate Pharmaceuticals Inc. Anterior Uveitis Treatment Product
Table 81. Eyegate Pharmaceuticals Inc. Revenue in Anterior Uveitis Treatment Business (2016-2021) & (US$ Million)
Table 82. Eyegate Pharmaceuticals Inc. Recent Development
Table 83. Clearside Biomedical Inc. Company Details
Table 84. Clearside Biomedical Inc. Business Overview
Table 85. Clearside Biomedical Inc. Anterior Uveitis Treatment Product
Table 86. Clearside Biomedical Inc. Revenue in Anterior Uveitis Treatment Business (2016-2021) & (US$ Million)
Table 87. Clearside Biomedical Inc. Recent Development
Table 88. Aldeyra Therapeutics Inc. Company Details
Table 89. Aldeyra Therapeutics Inc. Business Overview
Table 90. Aldeyra Therapeutics Inc. Anterior Uveitis Treatment Product
Table 91. Aldeyra Therapeutics Inc. Revenue in Anterior Uveitis Treatment Business (2016-2021) & (US$ Million)
Table 92. Aldeyra Therapeutics Inc. Recent Development
Table 93. Aciont Inc. Company Details
Table 94. Aciont Inc. Business Overview
Table 95. Aciont Inc. Anterior Uveitis Treatment Product
Table 96. Aciont Inc. Revenue in Anterior Uveitis Treatment Business (2016-2021) & (US$ Million)
Table 97. Aciont Inc. Recent Development
Table 98. Sirion Therapeutics Inc. Company Details
Table 99. Sirion Therapeutics Inc. Business Overview
Table 100. Sirion Therapeutics Inc. Revenue in Anterior Uveitis Treatment Business (2016-2021) & (US$ Million)
Table 101. Sirion Therapeutics Inc. Recent Development
Table 102. UCB Biopharma S.P.R.L. Company Details
Table 103. UCB Biopharma S.P.R.L. Business Overview
Table 104. UCB Biopharma S.P.R.L. Anterior Uveitis Treatment Product
Table 105. UCB Biopharma S.P.R.L. Revenue in Anterior Uveitis Treatment Business (2016-2021) & (US$ Million)
Table 106. UCB Biopharma S.P.R.L. Recent Development
Table 107. Lux Biosciences Inc. Company Details
Table 108. Lux Biosciences Inc. Business Overview
Table 109. Lux Biosciences Inc. Anterior Uveitis Treatment Product
Table 110. Lux Biosciences Inc. Revenue in Anterior Uveitis Treatment Business (2016-2021) & (US$ Million)
Table 111. Lux Biosciences Inc. Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Anterior Uveitis Treatment Market Share by Type: 2020 VS 2027
Figure 2. Corticosteroids Features
Figure 3. Cycloplegic Agents Features
Figure 4. Anti-TNF Agents Features
Figure 5. Immunosuppressants Features
Figure 6. Global Anterior Uveitis Treatment Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Others Case Studies
Figure 10. Anterior Uveitis Treatment Report Years Considered
Figure 11. Global Anterior Uveitis Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Anterior Uveitis Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Anterior Uveitis Treatment Market Share by Regions: 2020 VS 2027
Figure 14. Global Anterior Uveitis Treatment Market Share by Regions (2022-2027)
Figure 15. Global Anterior Uveitis Treatment Market Share by Players in 2020
Figure 16. Global Top Anterior Uveitis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anterior Uveitis Treatment as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Anterior Uveitis Treatment Revenue in 2020
Figure 18. Global Anterior Uveitis Treatment Revenue Market Share by Type (2016-2021)
Figure 19. Global Anterior Uveitis Treatment Revenue Market Share by Type (2022-2027)
Figure 20. North America Anterior Uveitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Anterior Uveitis Treatment Market Share by Type (2016-2027)
Figure 22. North America Anterior Uveitis Treatment Market Share by Application (2016-2027)
Figure 23. North America Anterior Uveitis Treatment Market Share by Country (2016-2027)
Figure 24. United States Anterior Uveitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Anterior Uveitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Anterior Uveitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Anterior Uveitis Treatment Market Share by Type (2016-2027)
Figure 28. Europe Anterior Uveitis Treatment Market Share by Application (2016-2027)
Figure 29. Europe Anterior Uveitis Treatment Market Share by Country (2016-2027)
Figure 30. Germany Anterior Uveitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Anterior Uveitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Anterior Uveitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Anterior Uveitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Anterior Uveitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Anterior Uveitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Anterior Uveitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Anterior Uveitis Treatment Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Anterior Uveitis Treatment Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Anterior Uveitis Treatment Market Share by Region (2016-2027)
Figure 40. China Anterior Uveitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Anterior Uveitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Anterior Uveitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Anterior Uveitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Anterior Uveitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Anterior Uveitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Anterior Uveitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Anterior Uveitis Treatment Market Share by Type (2016-2027)
Figure 48. Latin America Anterior Uveitis Treatment Market Share by Application (2016-2027)
Figure 49. Latin America Anterior Uveitis Treatment Market Share by Country (2016-2027)
Figure 50. Mexico Anterior Uveitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Anterior Uveitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Anterior Uveitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Anterior Uveitis Treatment Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Anterior Uveitis Treatment Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Anterior Uveitis Treatment Market Share by Country (2016-2027)
Figure 56. Turkey Anterior Uveitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Anterior Uveitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Anterior Uveitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Novartis AG Revenue Growth Rate in Anterior Uveitis Treatment Business (2016-2021)
Figure 60. Santen Pharmaceutical Co. Revenue Growth Rate in Anterior Uveitis Treatment Business (2016-2021)
Figure 61. AbbVie Inc. Revenue Growth Rate in Anterior Uveitis Treatment Business (2016-2021)
Figure 62. Eyegate Pharmaceuticals Inc. Revenue Growth Rate in Anterior Uveitis Treatment Business (2016-2021)
Figure 63. Clearside Biomedical Inc. Revenue Growth Rate in Anterior Uveitis Treatment Business (2016-2021)
Figure 64. Aldeyra Therapeutics Inc. Revenue Growth Rate in Anterior Uveitis Treatment Business (2016-2021)
Figure 65. Aciont Inc. Revenue Growth Rate in Anterior Uveitis Treatment Business (2016-2021)
Figure 66. Sirion Therapeutics Inc. Revenue Growth Rate in Anterior Uveitis Treatment Business (2016-2021)
Figure 67. UCB Biopharma S.P.R.L. Revenue Growth Rate in Anterior Uveitis Treatment Business (2016-2021)
Figure 68. Lux Biosciences Inc. Revenue Growth Rate in Anterior Uveitis Treatment Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

以下、関連資料のご紹介

世界の直接前方アプローチ市場規模・現状・予測（2021年-2027年）

Global Direct Anterior Approach Market Size, Status and Forecast 2021-2027
QYR2104Z1903 2021年4月 93Pages
QYResearch社発行の本調査資料では、直接前方アプローチのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（金属材料、合金材料、樹脂材料）、用途別市場規模（45歳以下、45〜65歳、65歳以上）、主要地域別市場規模（北米、アメリカ、ヨーロッパ...

世界の直接前方アプローチ市場規模・現状・予測（2021年-2027年）

世界の直接型前方股関節置換術市場規模・現状・予測（2021年-2027年）

Global Direct Anterior Hip Replacement Market Size, Status and Forecast 2021-2027
QYR2104Z1904 2021年4月 91Pages
QYResearch社発行の本調査資料では、直接型前方股関節置換術のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（金属材料、合金材料、樹脂材料）、用途別市場規模（45歳以下、45〜65歳、65歳以上）、主要地域別市場規模（北米、アメリカ、ヨーロ...

世界の十字靭帯診断・治療市場規模・現状・予測（2021年-2027年）

Global Cruciate Ligament Diagnosis and Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z1659 2021年4月 95Pages
QYResearch社発行の本調査資料では、十字靭帯診断・治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（後十字靭帯（PCL）、前十字靭帯（ACL））、用途別市場規模（病院、整形外科クリニック、外来手術センター（ASC））、主要地域別市場規...

世界の後天性血友病A治療市場規模・現状・予測（2021年-2027年）

Global Acquired hemophilia A Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0029 2021年4月 97Pages
QYResearch社発行の本調査資料では、後天性血友病A治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（200IU、250IU）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、イン...

世界のスウェーデンポルフィリン症治療市場規模・現状・予測（2021年-2027年）

Global Swedish Porphyria Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z5520 2021年4月 99Pages
QYResearch社発行の本調査資料では、スウェーデンポルフィリン症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（350mg、313mg）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国...

世界の急性間欠性ポルフィリン症（AIP）治療市場規模・現状・予測（2021年-2027年）

Global Acute Intermittent Porphyria Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0060 2021年4月 92Pages
QYResearch社発行の本調査資料では、急性間欠性ポルフィリン症（AIP）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（350mg、313mg）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日...

世界のMSD治療市場規模・現状・予測（2021年-2027年）

Global MSD Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z3939 2021年4月 91Pages
QYResearch社発行の本調査資料では、MSD治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（OTC、Rx薬）、用途別市場規模（病院、小売薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジ...

世界のアデノシンデアミナーゼ欠損症（ADA）治療市場規模・現状・予測（2021年-2027年）

Global Adenosine Deaminase Deficiency Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0096 2021年4月 96Pages
QYResearch社発行の本調査資料では、アデノシンデアミナーゼ欠損症（ADA）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（アダーゲン、レブコビ）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、...

世界の軟骨無形成症治療市場規模・現状・予測（2021年-2027年）

Global Achondroplasia Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0013 2021年4月 92Pages
QYResearch社発行の本調査資料では、軟骨無形成症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（RBM-007、TA-46、B-701、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロ...

世界の直接前方アプローチ市場規模・現状・予測（2021年-2027年） Osteoarthritis is one of the prime reasons for aggravating hip pain in the elderly. Direct anterior approach (DAA) is a minimally invasive surgery made possible with a small incision without cutting any tendons. This technique has benefits such as low surgery time, reduced post-surgery pain, and rap…
世界の直接前方アプローチ市場規模・現状・予測（2021年-2027年） Osteoarthritis is one of the prime reasons for aggravating hip pain in the elderly. Direct anterior approach (DAA) is a minimally invasive surgery made possible with a small incision without cutting any tendons. This technique has benefits such as low surgery time, reduced post-surgery pain, and rap…
世界の直接型前方股関節置換術市場規模・現状・予測（2021年-2027年） A hip replacement is an invasive surgical procedure, used to remove a diseased or fractured hip joint and replace it with an artificial joint or prosthesis. Osteoarthritis is one of the most common factors for hip diseases. Structures within the hip (such as the cartilage or bony joint surfaces) may…
世界の頸椎前方アプローチデバイスパッケージ市場 2021：企業別、地域別、種類・用途別 The Cervical Anterior Approach Device Package market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizat…
世界の孤児肺疾患治療市場規模・現状・予測（2021年-2027年） Orphan illnesses are those which are not generally looked into, those where particular medicines are not accessible, and those which may just be of restricted enthusiasm to researchers and specialists. Orphan lung diseases are exemplified by the purported disregarded infectious diseases, which are e…